Equities analysts predict that Masimo Corporation (NASDAQ:MASI) will report earnings per share of $0.53 for the current quarter, according to Zacks. Four analysts have made estimates for Masimo Corporation’s earnings. The highest EPS estimate is $0.54 and the lowest is $0.53. Masimo Corporation posted earnings of $0.47 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 12.8%. The business is expected to issue its next earnings results on Wednesday, November 1st.

According to Zacks, analysts expect that Masimo Corporation will report full-year earnings of $2.80 per share for the current financial year, with EPS estimates ranging from $2.80 to $2.81. For the next fiscal year, analysts anticipate that the company will post earnings of $2.53 per share, with EPS estimates ranging from $2.41 to $2.74. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that cover Masimo Corporation.

Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.12. The business had revenue of $192.90 million for the quarter, compared to the consensus estimate of $189.03 million. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The business’s revenue was up 11.8% on a year-over-year basis. During the same quarter last year, the business posted $0.57 EPS.

A number of brokerages recently issued reports on MASI. Roth Capital lifted their price objective on shares of Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. BidaskClub cut shares of Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Zacks Investment Research raised shares of Masimo Corporation from a “sell” rating to a “hold” rating in a research note on Tuesday, July 11th. Stifel Nicolaus began coverage on shares of Masimo Corporation in a research note on Monday, July 10th. They issued a “buy” rating and a $105.00 price objective on the stock. Finally, Wedbush reissued an “outperform” rating and issued a $112.00 price objective on shares of Masimo Corporation in a research note on Monday, May 22nd. One analyst has rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the company’s stock. Masimo Corporation presently has a consensus rating of “Hold” and an average target price of $95.00.

COPYRIGHT VIOLATION WARNING: “Masimo Corporation (MASI) Expected to Announce Earnings of $0.53 Per Share” was published by American Banking News and is the property of of American Banking News. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/08/30/masimo-corporation-masi-expected-to-announce-earnings-of-0-53-per-share.html.

Shares of Masimo Corporation (MASI) traded down 0.18% during mid-day trading on Wednesday, hitting $81.85. The company had a trading volume of 28,734 shares. Masimo Corporation has a 12-month low of $53.78 and a 12-month high of $104.71. The firm has a market cap of $4.25 billion, a PE ratio of 13.42 and a beta of 0.80. The firm’s 50 day moving average is $90.44 and its 200-day moving average is $90.72.

In other Masimo Corporation news, COO Anand Sampath sold 40,000 shares of the business’s stock in a transaction on Tuesday, July 11th. The shares were sold at an average price of $92.00, for a total transaction of $3,680,000.00. Following the sale, the chief operating officer now owns 20,000 shares of the company’s stock, valued at $1,840,000. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Sanford Fitch sold 11,000 shares of the business’s stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $87.25, for a total transaction of $959,750.00. Following the sale, the director now directly owns 72,249 shares in the company, valued at approximately $6,303,725.25. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 126,000 shares of company stock worth $11,732,930. Insiders own 16.60% of the company’s stock.

Hedge funds have recently bought and sold shares of the company. Fortaleza Asset Management Inc. bought a new stake in Masimo Corporation during the second quarter worth $106,000. Neuburgh Advisers LLC boosted its stake in Masimo Corporation by 6.4% in the first quarter. Neuburgh Advisers LLC now owns 1,328 shares of the medical equipment provider’s stock worth $124,000 after buying an additional 80 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Masimo Corporation by 32.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,782 shares of the medical equipment provider’s stock worth $166,000 after buying an additional 434 shares during the last quarter. Glen Harbor Capital Management LLC boosted its stake in Masimo Corporation by 6.4% in the first quarter. Glen Harbor Capital Management LLC now owns 1,826 shares of the medical equipment provider’s stock worth $170,000 after buying an additional 110 shares during the last quarter. Finally, Dubuque Bank & Trust Co. boosted its stake in Masimo Corporation by 3.4% in the second quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock worth $170,000 after buying an additional 61 shares during the last quarter. 83.27% of the stock is currently owned by hedge funds and other institutional investors.

Masimo Corporation Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Get a free copy of the Zacks research report on Masimo Corporation (MASI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.